Stockscreener 앱 받기
361.83
0.57%
1.835
전일 마감가:
$360.00
열려 있는:
$360.46
하루 거래량:
269.37K
Relative Volume:
0.19
시가총액:
$70.39B
수익:
$325.78B
순이익/손실:
$1.64B
주가수익비율:
43.52
EPS:
8.3139
순현금흐름:
$3.61B
1주 성능:
+9.72%
1개월 성능:
+7.85%
6개월 성능:
+24.54%
1년 성능:
+46.72%
1일 변동 폭
$358.29
$362.39
1주일 범위
$332.99
$367.28
52주 변동 폭
$237.71
$377.54
Cencora Inc Stock (COR) Company Profile
명칭
Cencora Inc
전화
610-727-7000
주소
1 WEST FIRST AVENUE, CONSHOHOCKEN
Compare COR vs MCK, CAH, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
361.84 | 70.03B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
MCK
Mckesson Corporation
|
940.06 | 114.55B | 397.96B | 4.55B | 9.64B | 34.77 |
|
CAH
Cardinal Health Inc
|
223.72 | 51.83B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
HSIC
Henry Schein Inc
|
81.22 | 9.54B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.41 | 793.60M | 2.22M | -5.63M | -1.68M | -0.24 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-29 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2026-01-22 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-06-03 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | 재개 | Mizuho | Outperform |
| 2024-09-18 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-12-14 | 개시 | Wells Fargo | Equal Weight |
| 2023-03-31 | 개시 | Citigroup | Buy |
| 2023-01-31 | 재개 | Evercore ISI | Outperform |
| 2022-10-11 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-08-22 | 재개 | Morgan Stanley | Equal-Weight |
| 2022-07-11 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-06-07 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2022-05-26 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-04-12 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2021-03-12 | 재개 | Evercore ISI | In-line |
| 2021-02-04 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2021-02-02 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2021-01-06 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2021-01-06 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | 개시 | Mizuho | Neutral |
| 2020-08-06 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | 개시 | Barclays | Underweight |
| 2020-06-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | 재개 | Credit Suisse | Outperform |
| 2020-04-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2020-03-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-02-11 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | 개시 | Deutsche Bank | Hold |
| 2019-07-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | 개시 | Guggenheim | Buy |
| 2019-04-10 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-02-11 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2019-01-17 | 개시 | UBS | Buy |
| 2018-12-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2018-10-26 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | 개시 | Berenberg | Buy |
| 2018-07-17 | 재개 | Stifel | Hold |
| 2018-04-09 | 개시 | MoffettNathanson | Buy |
| 2018-03-12 | 업그레이드 | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | 개시 | JP Morgan | Neutral |
| 2017-09-22 | 개시 | William Blair | Outperform |
모두보기
Cencora Inc 주식(COR)의 최신 뉴스
Ex-Dividend Reminder: Cencora, Amgen and Oppenheimer Holdings - Nasdaq
5 Revealing Analyst Questions From Cencora's Q4 Earnings Call - Finviz
Versor Investments LP Makes New Investment in Cencora, Inc. $COR - MarketBeat
ING Groep NV Boosts Stake in Cencora, Inc. $COR - MarketBeat
How Investors Are Reacting To Cencora (COR) US$3 Billion Senior Notes To Term Out Acquisition Debt - simplywall.st
Cencora prices $3 billion in senior notes across multiple maturities By Investing.com - Investing.com Nigeria
What are Wall Street analysts' target price for Cencora stock? - MSN
Cencora Prices Senior Notes - marketscreener.com
Cencora prices $3 billion in senior notes across multiple maturities - Investing.com
Cencora prices five bond issues to repay OneOncology acquisition credit - Stock Titan
Cencora (COR) Receives Analyst Rating Update from JP Morgan | CO - GuruFocus
Beyond The Numbers: 6 Analysts Discuss Cencora Stock - Benzinga
Cencora files for five-part senior notes offering size not diclosed - marketscreener.com
Wells Fargo Raises Price Target on Cencora (COR) to $429.00 | CO - GuruFocus
Cencora, Inc. (COR) Announces Strategic Reorganization of Busine - GuruFocus
Cencora Updates Segment Reporting Following Strategic Business Review - TipRanks
Cencora, Inc Revises Financial Reporting Structure - TradingView
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Johnson Investment Counsel Inc. Sells 11,354 Shares of Cencora, Inc. $COR - MarketBeat
Chief Executives for Corporate Purpose Announces Covista Chairman and CEO Steve Beard, Cencora Inc. Former Executive Chair Steven H. Collis, and Ann Fairchild, interim President and CEO of Siemens USA Joining Board of Directors - Yahoo Finance
Is It Too Late To Consider Cencora (COR) After A 46% One-Year Rally? - Yahoo Finance
Envestnet Asset Management Inc. Lowers Stock Holdings in Cencora, Inc. $COR - MarketBeat
Aurdan Capital Management LLC Sells 4,004 Shares of Cencora, Inc. $COR - MarketBeat
Cencora (COR) Valuation Check After Recent Share Price Momentum And Intrinsic Value Discount - simplywall.st
Cencora (COR) Stock Trades Up, Here Is Why - Finviz
Cencora Inc (COR) Trading Down 0% on Feb 5 - GuruFocus
Cencora Lifts 2026 Sales Outlook Despite Q1 Revenue Miss - Sahm
Cencora Q1 2026 Earnings: Profit Exceeds Expectations, Revenue at $85.93BNews and Statistics - IndexBox
Cencora, Inc. $COR Shares Sold by Triglav Investments D.O.O. - MarketBeat
COR Q4 Deep Dive: Specialty Expansion and OneOncology Drive Strategic Shifts - Finviz
BI Asset Management Fondsmaeglerselskab A S Raises Holdings in Cencora, Inc. $COR - MarketBeat
16,364 Shares in Cencora, Inc. $COR Purchased by ABN AMRO Bank N.V. - MarketBeat
Cencora, Inc. (COR) Shares Slide as Revenue Miss Offsets Raised Operating Guidance - AlphaStreet News
Decoding Cencora Inc (COR): A Strategic SWOT Insight - GuruFocus
Cencora Q1 Earnings Call Highlights - Yahoo Finance
Jefferies reiterates Buy rating on Cencora stock, sees upside potential By Investing.com - Investing.com Australia
Cencora (COR) Margin Stays Near 0.5% As High P/E Tests Bullish Growth Narratives - simplywall.st
Cencora Earnings Call: Specialty Strength, Guidance Raised - TipRanks
Cencora Q1 2026 presentation: EPS beat overshadowed by revenue miss and stock drop - Investing.com Nigeria
Cencora Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Cencora Inc (COR) Q1 2026 Earnings Call Highlights: Strong US Gr - GuruFocus
Cencora Inc (COR) Q1 2026 Earnings Call Highlights: Strong US Growth Amid International Challenges By GuruFocus - Investing.com Canada
Jefferies reiterates Buy rating on Cencora stock, sees upside potential - Investing.com
Cencora, Inc. SEC 10-Q Report - TradingView
Leerink reiterates Outperform rating on Cencora stock, citing durable growth By Investing.com - Investing.com Canada
Leerink reiterates Outperform rating on Cencora stock, citing durable growth - Investing.com
Cencora Well-Positioned for Durable Long-Term Growth From Strong Demand and Specialty Investments - Morningstar
Cencora, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2025 - marketscreener.com
Cencora Stock Down Despite Q1 Earnings Beat, Gross Margin Improves - Yahoo Finance
Cencora Lifts 2026 Sales Outlook Despite Q1 Revenue Miss - Benzinga
Cencora beats quarterly profit estimates on strong demand for specialty medicines - marketscreener.com
Cencora Inc (COR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.41%
2.08%
자본화:
|
볼륨(24시간):